BSND | Bartter syndrome, infantile, with sensorineural deafness (Barttin) | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
BST2 | Bone marrow stromal cell antigen 2 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
BTN2A2 | Butyrophilin, subfamily 2, member A2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BTN3A3 | Butyrophilin, subfamily 3, member A3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BTNL8 | Butyrophilin-like 8 | Predicted membrane proteins
| | | | | Group enriched |
C14orf2 | Chromosome 14 open reading frame 2 | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
C16orf89 | Chromosome 16 open reading frame 89 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C17orf78 | Chromosome 17 open reading frame 78 | Predicted membrane proteins
| | | | | Group enriched |
C19orf18 | Chromosome 19 open reading frame 18 | Predicted membrane proteins
| | | | | Tissue enriched |
C19orf24 | Chromosome 19 open reading frame 24 | Predicted membrane proteins
| | | | | Expressed in all |
C1orf159 | Chromosome 1 open reading frame 159 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C1orf85 | Chromosome 1 open reading frame 85 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C2orf82 | Chromosome 2 open reading frame 82 | Predicted membrane proteins
| | | | | Tissue enhanced |
C4orf3 | Chromosome 4 open reading frame 3 | Predicted membrane proteins
| | | | | Expressed in all |
C5orf60 | Chromosome 5 open reading frame 60 | Predicted membrane proteins
| | | | | Tissue enriched |
CA12 | Carbonic anhydrase XII | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CA14 | Carbonic anhydrase XIV | Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
CABLES2 | Cdk5 and Abl enzyme substrate 2 | Predicted membrane proteins
| | | | | Tissue enriched |
CACNA2D1 | Calcium channel, voltage-dependent, alpha 2/delta subunit 1 | FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CADM1 | Cell adhesion molecule 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CADM2 | Cell adhesion molecule 2 | Predicted membrane proteins
| | | | | Tissue enriched |
CADM3 | Cell adhesion molecule 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CALD1 | Caldesmon 1 | Cytoskeleton related proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CAMK2A | Calcium/calmodulin-dependent protein kinase II alpha | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CAMK2B | Calcium/calmodulin-dependent protein kinase II beta | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CAMK4 | Calcium/calmodulin-dependent protein kinase IV | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2, beta | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
CANT1 | Calcium activated nucleotidase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CARD8 | Caspase recruitment domain family, member 8 | Predicted membrane proteins
| | | | | Expressed in all |
CASK | Calcium/calmodulin-dependent serine protein kinase (MAGUK family) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CAV2 | Caveolin 2 | Predicted membrane proteins
| | | | | Mixed |
CAV3 | Caveolin 3 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CCDC107 | Coiled-coil domain containing 107 | Predicted membrane proteins
| | | | | Expressed in all |
CCDC155 | Coiled-coil domain containing 155 | Predicted membrane proteins
| | | | | Tissue enriched |
CCDC47 | Coiled-coil domain containing 47 | Predicted membrane proteins
| | | | | Expressed in all |
CCDC51 | Coiled-coil domain containing 51 | Predicted membrane proteins
| | | | | Expressed in all |
CCDC64 | Coiled-coil domain containing 64 | Predicted membrane proteins
| | | | | Tissue enhanced |
CCDC90B | Coiled-coil domain containing 90B | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
CD101 | CD101 molecule | CD markers Predicted membrane proteins
| | | | | Mixed |
CD151 | CD151 molecule (Raph blood group) | Blood group antigen proteins CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CD163 | CD163 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD163L1 | CD163 molecule-like 1 | CD markers Predicted membrane proteins
| | | | | Mixed |
CD164 | CD164 molecule, sialomucin | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD164L2 | CD164 sialomucin-like 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD180 | CD180 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD1A | CD1a molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |